Company Announcements

Publication of Amended and Restated Final Terms

Source: RNS
RNS Number : 9156I
Barclays PLC
16 December 2020
 

Publication of Amended and Restated Final Terms

The following amended and restated final terms dated 16 December 2020 (the "Amended and Restated Final Terms") are available for viewing:

Amended and Restated Final Terms in relation to Barclays PLC's issue of £1,000,000,000 2.375 per cent. Reset Notes due 2023 (ISIN: XS1695301900) under the Barclays PLC £60,000,000,000 Debt Issuance Programme.

The Amended and Restated Final Terms amend and restate the Final Terms dated 4 October 2017 relating to the Notes.

Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.

To view the full document, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/9156I_1-2020-12-16.pdf

A copy of the Amended and Restated Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism 

For further information, please contact:

Barclays Treasury
1 Churchill Place
London E14 5HP
United Kingdom

 

DISCLAIMER - INTENDED ADDRESSEES

IMPORTANT: You must read the following before continuing: The following applies to the Amended and Restated Final Terms available by clicking on the link above, and you are therefore advised to read this carefully before reading, accessing or making any other use of the Amended and Restated Final Terms. In accessing the Amended and Restated Final Terms, you agree to be bound by the following terms and conditions, including any modifications to them, any time you receive any information from us as a result of such access.

The Amended and Restated Final Terms referred to above must be read in conjunction with the base prospectus dated 28 February 2017, the base prospectus supplement dated 4 May 2017 and the base prospectus supplement dated 31 July 2017, relating to the above programme (the "Base Prospectus").

THE AMENDED AND RESTATED FINAL TERMS MAY NOT BE FORWARDED OR DISTRIBUTED OTHER THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER WHATSOEVER. THE AMENDED AND RESTATED FINAL TERMS MAY ONLY BE DISTRIBUTED OUTSIDE THE UNITED STATES TO PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED IN, AND IN RELIANCE ON, REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR WITHIN THE UNITED STATES TO QIBs (AS DEFINED BELOW) IN ACCORDANCE WITH RULE 144A UNDER THE SECURITIES ACT ("RULE 144A"). ANY FORWARDING, DISTRIBUTION OR REPRODUCTION OF THE AMENDED AND RESTATED FINAL TERMS IN WHOLE OR IN PART IS PROHIBITED. FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER JURISDICTIONS.

NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO SO. ANY NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE AMENDED AND RESTATED FINAL TERMS HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER JURISDICTION. ANY NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE AMENDED AND RESTATED FINAL TERMS MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (1) IN AN OFFSHORE TRANSACTION TO OR FOR THE BENEFIT OF A PERSON THAT IS NOT A U.S. PERSON IN ACCORDANCE WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT OR (2) IN ACCORDANCE WITH RULE 144A UNDER THE SECURITIES ACT TO PERSONS REASONABLY BELIEVED TO BE QUALIFIED INSTITUTIONAL BUYERS (EACH A "QIB") WITHIN THE MEANING OF RULE 144A.

Please note that the information contained in the Amended and Restated Final Terms and the Prospectus referred to above may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Amended and Restated Final Terms and/or the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Amended and Restated Final Terms and/or the Prospectus is not addressed. Prior to relying on the information contained in the Amended and Restated Final Terms and/or Base Prospectus you must ascertain from the Amended and Restated Final Terms and Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Confirmation of your Representation: In order to be eligible to view the Amended and Restated Final Terms or make an investment decision with respect to any Notes issued or to be issued pursuant to the Amended and Restated Final Terms, you must be (i) a person other than a U.S. person (within the meaning of Regulation S under the Securities Act) or (ii) a QIB that is acquiring the securities for its own account or for the account of another QIB. By accessing the Amended and Restated Final Terms, you shall be deemed to have represented that you and any customers you represent are not a U.S. person or that you are a QIB (as the case may be), and that you consent to delivery of the Amended and Restated Final Terms via electronic publication.

You are reminded that the Amended and Restated Final Terms have been made available to you on the basis that you are a person into whose possession the Amended and Restated Final Terms may be lawfully delivered in accordance with the laws of the jurisdiction in which you are located and you may not, nor are you authorised to, deliver the Amended and Restated Final Terms to any other person.

The Amended and Restated Final Terms do not constitute, and may not be used in connection with, an offer or solicitation in any place where offers or solicitations are not permitted by law. If a jurisdiction requires that the offering be made by a licensed broker or dealer and the underwriters or any affiliate of the underwriters is a licensed broker or dealer in that jurisdiction, the offering shall be deemed to be made by the underwriters or such affiliate on behalf of the issuer in such jurisdiction. Under no circumstances shall the Amended and Restated Final Terms constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of any Notes issued or to be issued pursuant to the Amended and Restated Final Terms, in any jurisdiction in which such offer, solicitation or sale would be unlawful.

The Amended and Restated Final Terms has been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently none of the issuer, its advisers nor any person who controls any of them nor any director, officer, employee nor agent of it or affiliate of any such person accepts any liability or responsibility whatsoever in respect of any difference between the Amended and Restated Final Terms made available to you in electronic format and the hard copy version available to you on request from the issuer.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTEAXAKFAEEFFA